Cutera

What Cutera does

Cutera is a Nasdaq-listed medical aesthetics company (ticker: CUTR), founded in 1998 and headquartered in Brisbane, California, that designs and manufactures energy-based aesthetic devices for dermatologists, plastic surgeons, and medical spas. The company's portfolio spans laser platforms (Nd:YAG, CO2, 1726nm), radiofrequency (RF) systems including monopolar and microneedling, and intense pulsed light (IPL) systems. Flagship products include AviClear (the first FDA-cleared energy device for long-term acne treatment at 1726nm), the truSculpt/truFlex/truBody body-sculpting franchise (with clinically demonstrated ~24% average fat reduction), the Secret RF/PRO/DUO resurfacing line, excel V/V+ for vascular and pigmentary conditions, xeo and xeo+ multi-application platforms, enlighten for tattoo and pigment removal, and excel HR for hair removal. The company holds multiple registered trademarks (AviClear, truSculpt, truFlex, Secret, excel, enlighten, xeo, truBody, Laser Genesis, PICO Genesis) that anchor its brand across dermatology and consumer-facing publications.

Cutera generates revenue through three streams: capital equipment sales at $120,000–$300,000 per platform, recurring consumables (handpieces and tips), and service contracts (which grew 7% in Q2 2024). Distribution is primarily direct enterprise field sales targeting aesthetic physicians and dermatology practices, supplemented by wholly-owned regional subsidiaries across the US, Australia, Belgium, France, Germany, Japan, Switzerland, and the UK. A strategic channel partnership with L'Oréal Japan Co. extends reach into the Japanese medical aesthetics market via exclusive distribution of SkinCeuticals products. Marketing emphasizes clinical evidence, FDA clearances, and provider education through Cutera Academy webinars, trade shows, and a Provider Finder tool that drives patient demand to equipped practitioners.

The company has encountered material headwinds. Q2 2024 consolidated revenue of $34.4M missed expectations, especially in North America, despite 41% international AviClear growth and 7% service revenue growth. The company has executed leadership changes and ongoing restructuring and cost-reduction measures, and filed for Chapter 11 bankruptcy protection in March 2025 amid industry-wide pressure from inflation, supply-chain disruption, and shifting consumer spending. Despite this, Cutera continues to operate globally and pursue product-line expansion, including FDA-cleared expansion of truFlex into rehabilitative and therapeutic indications.

Name

Cutera

Legal name

Cutera, Inc.

Website

https://cutera.com

Company type

Public

Founded year

1998

Operating status

Operating

Headcount range

251–500 employees

Short description

Cutera is a Nasdaq-listed medical aesthetics company that designs FDA-cleared laser, radiofrequency, and IPL devices for dermatologists, plastic surgeons, and medical spas, with a portfolio spanning acne treatment, body sculpting, skin revitalization, and tattoo removal.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Professional Skincare & Facial Treatments (CRABALAF)

Keywords

• Aesthetic medical devices
• Laser aesthetic systems
• Radiofrequency devices
• Dermatology equipment
• Energy-based aesthetics

Headquarters

HQ city

Brisbane

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain

Revenue model

1. Capital Equipment Sales: Sale of laser and radiofrequency aesthetic devices to dermatology clinics and medical spas. Equipment includes xeo+ platform, AviClear, truSculpt, truFlex, Secret RF, excel V+, and enlighten systems. Revenue recognition occurs upon device delivery with typical capital expenditure ranging from $120,000 to $300,000 per unit.
2. Consumables: Recurring revenue from consumables used with Cutera devices during patient treatments. This includes handpieces, tips, and other disposable components that require replacement over the device lifecycle.
3. Service Contracts: Recurring service and maintenance revenue from service contracts offered to device owners. The company reported 7% growth in service revenue, providing predictable recurring income stream.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Cutera designs, manufactures, and sells energy-based medical aesthetic devices—including laser platforms (Nd:YAG, CO2, picosecond), radiofrequency systems, and intense pulsed light (IPL) systems—for dermatology clinics, plastic surgery practices, and medical spas. Its portfolio addresses acne treatment, body sculpting, skin revitalization, hair removal, tattoo removal, and vascular/pigmentary lesions. Revenue comes primarily from capital equipment sales ($120,000–$300,000 per unit), with recurring income from consumables and service contracts.

Product overview

Cutera is a medical aesthetics company offering a portfolio of energy-based devices for dermatology and aesthetic clinics. The product portfolio includes laser and RF platforms for acne treatment (AviClear), body sculpting (truSculpt, truFlex, truBody platform), skin revitalization and resurfacing (Secret RF, Secret PRO, Secret DUO, excel V, excel V+), hair removal (excel HR, xeo+), tattoo removal (enlighten), and pigmented/vascular lesion treatment (xeo+, xeo). The devices range from single-application systems to multi-platform solutions like xeo+ that combine Nd:YAG laser with IPL technology. Products are designed for use in dermatology clinics and medical spas, with recurring revenue from consumables and service contracts.

Differentiator

Problem solved

Functional benefit

Brands

• truBody: Body sculpting solution combining truSculpt and truFlex technologies for fat reduction and muscle building.
• AviClear
• Secret
• excel
• xeo
• truSculpt
• truFlex
• enlighten
• excel HR

Products and services

• AviClear The first and original FDA-cleared energy device for the long-term treatment of all acne severities, using 1726nm laser technology. Designed for dermatologists and aesthetic physicians offering non-invasive acne treatment.
• xeo+ Multi-application laser and IPL platform for skin revitalization, vascular lesions, pigment reduction, hair removal, and wrinkle treatment, featuring Nd:YAG laser and tunable IPL handpieces. Targeted at dermatology and aesthetic practices seeking a single device for multiple treatment categories.
• truSculpt Non-invasive monopolar RF body sculpting platform delivering an average of 24% fat reduction in a single 15-minute hands-free treatment. Designed for aesthetic practices offering non-invasive body contouring.
• truFlex Rapid muscle sculpting technology using electrical muscle stimulation, now FDA-cleared for both aesthetic and rehabilitative/therapeutic applications. Targets body contouring and muscle development for aesthetic practices and rehabilitation providers.
• excel V+ Precision laser system designed with input from leading dermatologists for treating vascular and pigmentation conditions with power, precision, and performance. For dermatology and aesthetic practices.
• Secret PRO Combines RF microneedling with CO2 laser for skin resurfacing, designed to treat all skin layers with optimal results and minimal downtime. For aesthetic and dermatology practices.
• Secret RF RF microneedling system using gold-plated micro-needles to deliver fractional radiofrequency energy beneath the skin surface for revitalization and regeneration across all skin types. For dermatology practices.
• Secret DUO Combines RF microneedling with 1540nm and CO2 laser options for dynamic facial resurfacing and remodeling. For aesthetic practices seeking combined modality treatments.
• enlighten Versatile picosecond and nanosecond laser technology for multi-color tattoo removal, benign pigmented lesion treatment, and skin revitalization including PICO Genesis treatments. For dermatology and aesthetic practices.
• excel HR Laser system for hair removal, pigmented lesions, and vascular lesions. For dermatology and medical spa practices.
• excel V Laser system for skin revitalization, pigmented lesions, and vascular lesions. For dermatology practices.
• xeo Multi-application aesthetic platform for veins, pigment, wrinkles, hair removal, and skin revitalization. For aesthetic practices seeking consolidated device solutions.
• truBody Body sculpting solution combining truSculpt (fat reduction) and truFlex (muscle building) technologies for personalized body contouring results. A treatment platform offered to practices rather than a single device.

Quantifiable outcome

• 24% average fat reduction in single truSculpt treatment session
• +3 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• L'Oréal Japan Co.coreChannel Partner/ Reseller/ DistributorStrategic partnership for exclusive distribution of SkinCeuticals products to medical clinics in Japan. Cutera leverages this partnership to expand its presence in the Japanese medical aesthetics market by combining its device offerings with skincare product distribution through established retail channels.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Cynosure: Cynosure (owned by Hologic) is one of Cutera's closest direct competitors, offering a broad portfolio of energy-based aesthetic devices including laser and RF platforms for hair removal, skin revitalization, body contouring, and vascular treatments sold to dermatology clinics and medspas.
• Lumenis: Lumenis (now part of Boston Scientific) pioneered several energy-based aesthetic and surgical technologies and competes directly with Cutera in laser and IPL-based aesthetic treatments for dermatology and aesthetic practices.
• InMode: InMode develops RF-based aesthetic devices (BodyTite, Morpheus8, Evolve) that compete with Cutera's truSculpt, Secret RF, and truFlex in body contouring, microneedling, and muscle stimulation categories.
• Alma Lasers: Alma Lasers is a leading global developer of laser, RF, IPL, and ultrasound-based aesthetic and medical devices. It directly competes with Cutera across hair removal, body contouring, skin rejuvenation, and women's health indications, serving dermatologists, plastic surgeons, and medspas worldwide.
• Syneron Candela: Syneron Candela offers laser and IPL platforms (e.g., Gentle series, PicoWay, CO2RE) that compete directly with Cutera's excel, enlighten, and xeo+ systems across hair removal, pigmentation, tattoo removal, and skin revitalization indications.
• Venus Concept: Venus Concept markets energy-based devices for body contouring, hair removal, skin tightening, and facial rejuvenation, competing with Cutera across multiple product categories and serving similar dermatology and medspa customers.
• Solta Medical: Solta Medical (a Bausch Health company) markets Thermage, Fraxel, Clear+Brilliant, and Liposonix devices that overlap directly with Cutera's truSculpt (RF body contouring), Secret RF (microneedling), and enlighten (resurfacing) franchises.
• Sciton: Sciton manufactures premium laser and light-based aesthetic platforms for skin resurfacing, vascular lesions, and body contouring. It targets the same high-end dermatology and plastic surgery practices as Cutera, with overlapping indications.

Broad incumbents

• Allergan Aesthetics (AbbVie): Allergan Aesthetics, an AbbVie company, is a broad incumbent in medical aesthetics (Botox, CoolSculpting, SkinMedica) that competes with Cutera across practice economics and patient mindshare, even though its primary technology (injectables, cryolipolysis) differs from Cutera's energy-based devices.

Emerging players

• BTL Industries: BTL Industries is a fast-growing developer of non-invasive aesthetic devices (Emsculpt for muscle building, Emface, Exilis) that overlap with Cutera's truFlex and truSculpt franchises and have been taking share in body sculpting and facial aesthetics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Cutera
• YouTubeyoutube.com/@CuteraInc
• Facebookfacebook.com/Cutera
• LinkedInlinkedin.com/company/cutera
• Instagraminstagram.com/cuterainc
• TikToktiktok.com/@cuterainc

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries7 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cutera